Page 14 - Viral Vector News Today

Press release content from Business Wire. The AP news staff was not involved in its creation.

The chief scientific adviser to the Government warned that we face a ‘lumpy and bumpy’ road.

A new study reported systemic and mucosal immunity against SARS-CoV-2 via intranasal delivery of a vaccine containing recombinant SARS-CoV-2 antigens, nucleocapsid, and spike subunit.

Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Viral Vectors And Plasmid DNA Global Market Report 2022: By Product, By Application, By Disease, By...

Researchers evaluated the humoral and cellular immune memory induced by four COVID-19 vaccines representing three different vaccine platforms.

A synthetic viral vector and a novel surgical approach developed at Mass Eye and Ear has enabled efficient gene transfer into the inner ear of nonhuman primates, a research team working towards the development of effective treatments for hearing loss and vestibular disorders has reported.

Osaka Metropolitan University uses new “intersectional, anterograde transsynaptic targeting system” to reveal two different mouse brain circuits: the retina/primary visual cortex to the superior colliculus and the bilateral motor cortex to the dorsal striatum.

The market studies, insights and analysis carried out in Personalized Cancer Vaccines market analysis report keeps marketplace clearly into the focus which helps achieve business goal. SWOT analysis and Porter’s Five Forces Analysis are the two constantly and favourably used tools for structuring this market report....

A new study assesses breakthrough SARS-CoV-2 infections in vaccinated CLD patients with cirrhosis as compared to CLD patients without cirrhosis.

A new study assesses the comparative neutralizing antibody level elicited by three mRNA vaccine doses to a heterologous COVID-19 vaccine regimen.